ARCHIVES

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

Comprehensive Center NCAB Evaluations

June 2, 1978

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

June 24, 2005

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987

Aging Committee Hears Prospects For Immunotherapy

July 27, 1979

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage

August 7, 1998